Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK2849330 |
Synonyms | |
Therapy Description |
GSK2849330 is a monoclonal antibody that targets HER3 (ERBB3), potentially resulting in decreased proliferation of HER3-expressing tumors (PMID: 29610121, PMID: 30733323). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GSK2849330 | HER3 (ERBB3) Antibody 23 | GSK2849330 is a monoclonal antibody that targets HER3 (ERBB3), potentially resulting in decreased proliferation of HER3-expressing tumors (PMID: 29610121, PMID: 30733323). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT01966445 | Phase I | GSK2849330 | Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors | Completed | USA | NLD | AUS | 0 |